Supplements & Eliquis (Apixaban): Safety Reference

Share

November 17, 2026 · Yoon Hang Kim MD

Why Supplement Interactions Matter With Apixaban

Apixaban is metabolized primarily by CYP3A4 and transported by P-glycoprotein (P-gp). A supplement can interact with apixaban through three mechanisms:

  • CYP3A4 inhibition — slows apixaban clearance → higher drug levels → increased bleeding risk
  • CYP3A4 induction — speeds apixaban clearance → lower drug levels → reduced protection against clots
  • Additive antiplatelet/anticoagulant effect — the supplement itself inhibits platelet aggregation or clotting, compounding apixaban's blood-thinning action

Unlike warfarin, apixaban does not work through the vitamin K pathway, so dietary vitamin K intake does not affect its efficacy. "No known interaction" means no interaction has been documented — not that one has been proven absent.

GREEN — No Known Interaction at Standard Doses

These supplements have no documented pharmacokinetic or pharmacodynamic interaction with apixaban. Standard doses are assumed. Always disclose to prescriber/pharmacist.

Supplement

Status

Notes

Vitamin D3

No interaction

No CYP3A4 or P-gp involvement. Kidney disease or hypercalcemia requires separate caution.

Vitamin C (ascorbic acid)

No interaction

No documented interaction with apixaban at normal doses.

Vitamin B12 (cobalamin)

No interaction

Safe at standard supplementation doses.

Folate / Folic acid

No interaction

No CYP3A4, P-gp, or antiplatelet involvement.

Other B vitamins (B1, B2, B3, B5, B6, biotin)

No interaction

No documented interactions with apixaban.

Vitamin K

No interaction

Unlike warfarin, apixaban is not a vitamin K antagonist. No dietary restriction needed.

Zinc

No interaction

No effect on bleeding risk or apixaban metabolism.

Selenium

No interaction

No clinically significant interaction documented.

Iron

No interaction

Timing with other meds still matters for absorption.

Calcium

No interaction

Separate from thyroid hormones and some antibiotics for absorption.

Magnesium (glycinate, citrate, oxide)

Minor / No clinical concern

Not shown to increase bleeding risk at supplement doses. Kidney impairment requires separate caution.

Standard multivitamin (no herbal blends)

No interaction

Choose products without added botanicals or high-dose vitamin E.

CoQ10 (ubiquinone)

No interaction

Safe to combine. No clinically significant impact on anticoagulant drugs.

Collagen peptides

No interaction

Amino acid profile has no anticoagulant activity.

Glutathione

No interaction

No evidence of effect on apixaban's action or effectiveness.

Probiotics

No interaction

Start at low doses; avoid very high CFU or spore-forming products.

Vitamin A (standard doses)

No interaction

No CYP3A4 or antiplatelet involvement at standard doses.

Acetaminophen (Tylenol)

No interaction

First-line OTC pain option on Eliquis.

YELLOW — Use With Caution / Discuss With Prescriber

These supplements have theoretical or minor documented interactions with apixaban. Not automatically prohibited, but require an informed conversation with prescriber or pharmacist, particularly at higher doses.

Supplement

Risk Mechanism

Rating

Clinical Notes

Fish oil / Omega-3 (EPA, DHA)

Additive antiplatelet

Minor

Generally safe at normal doses. Theoretical risk at very high doses.

Melatonin

CYP3A4 inhibition + antiplatelet

Minor–Moderate

Use lowest effective dose; inform prescriber.

Ashwagandha

CYP3A4 induction (in vitro)

Minor

No clinically significant effect on coagulation in humans at typical doses.

NAC (N-acetyl cysteine)

Antiplatelet effect

Moderate

Findings based on IV; unclear if oral produces same effect.

Quercetin

CYP3A4 + P-gp inhibition

Moderate

May increase apixaban bioavailability. Use cautiously.

Echinacea

CYP3A4 modulation

Moderate

Induces hepatic but inhibits intestinal CYP3A4. Exercise caution.

Green tea extract (concentrated)

CYP3A4 inhibition + antiplatelet

Moderate

Moderate tea drinking likely fine; concentrated extract needs caution.

Garlic supplements (concentrated)

CYP3A4 modulation + antiplatelet

Moderate

Culinary garlic not a concern; concentrated pills warrant review.

Ginger extract (concentrated)

Additive antiplatelet

Moderate

Culinary ginger not a concern at normal amounts.

Panax ginseng

CYP3A4 modulation + antiplatelet

Moderate

Human studies have not confirmed antiplatelet effect.

Vitamin E (high-dose, >400 IU)

Additive bleeding risk

Moderate

Standard-dose in multivitamin is fine. High-dose is the concern.

Tocotrienols

Antiplatelet (theoretical)

Minor

400–800 mg daily with aspirin for 1 year showed no bleeding.

Resveratrol

CYP3A4 inhibition + antiplatelet

Moderate

No controlled human interaction studies with apixaban.

Motherwort

Antiplatelet (IV only)

Minor

Likely safe orally.

Goji berry

CYP3A4 inhibition (in vitro)

Minor

Not reported in humans.

RED — Avoid or Strongly Discourage With Apixaban

These supplements have major documented or strongly probable interactions. Avoid unless a prescriber has specifically reviewed and approved the combination with active monitoring.

Supplement

Risk Mechanism

Rating

Why It Matters

St. John's wort

Strong CYP3A4 + P-gp induction

Major

Most dangerous herbal interaction. Significantly reduces apixaban levels. Do not combine.

Turmeric / Curcumin (supplement)

CYP3A4 inhibition + antiplatelet

Major

Inhibits CYP3A4; has own antiplatelet effects. Culinary amounts differ from capsules.

Ginkgo biloba

Antiplatelet + CYP3A4

Major

Antiplatelet properties; may increase bleeding.

Dong quai

Additive anticoagulant

Major

Known anticoagulant properties. On Drugs.com major interaction list.

Goldenseal

CYP3A4 + P-gp inhibition

Major

Inhibits CYP3A4 and increases serum levels of substrates.

Berberine (standalone)

CYP3A4 + P-gp + antiplatelet

Major

Inhibits CYP3A4, P-gp, and platelet aggregation.

White willow bark

Antiplatelet (aspirin-like)

Major

Contains salicin. Additive bleeding risk with apixaban.

Feverfew

Antiplatelet

Moderate–Major

Inhibits platelet aggregation. Avoid without prescriber oversight.

Dan shen (Salvia miltiorrhiza)

Anticoagulant + antiplatelet + CYP3A4

Major

Well-documented anticoagulant/antiplatelet properties. Serious DOAC risk.

Schisandra

CYP3A4 inhibition

Major

Increases levels of CYP3A4 substrates.

Nattokinase

Direct fibrinolytic

Major

Directly breaks down fibrin. Serious bleeding risk with any anticoagulant.

Bromelain (high-dose)

Antiplatelet + fibrinolytic

Moderate–Major

High supplemental doses only. Dietary pineapple not a concern.

MSK About Herbs — Oncology-Relevant Interactions

Memorial Sloan Kettering's Integrative Medicine Service maintains the About Herbs database (aboutherbs.com), providing evidence-based interaction summaries for over 300 dietary supplements. Summary from MSK's published data and Lam et al., J Pharm Pract 2019 (PMC6777855).

Herb / Supplement

MSK Interaction Finding

Tier

Turmeric / Curcumin

In vitro platelet inhibition; CYP2C9 inhibition (IC50 4.3 μM). Oral intake unlikely to reach CYP3A4-inhibiting concentrations.

RED

Reishi mushroom

MSK: "Reishi can increase the risk of bleeding" with anticoagulants. CYP2E1, CYP1A2, CYP3A inhibition in vitro.

RED

Chaga mushroom

Platelet aggregation inhibition in murine model. High oxalate content; toxic in renal disease.

YELLOW

Boswellia (frankincense)

Alcohol extract inhibits platelet aggregation. Water extract did not.

YELLOW

Ashwagandha

Per MSK: does NOT interact with CYP3A4 or CYP2D6 in human liver microsomes.

GREEN

Green tea (EGCG)

Oral EGCG (even 3 g) unlikely to significantly inhibit CYP2D6. High fasting doses → liver toxicity.

GREEN/YELLOW

Dandelion

CYP1A2 and CYP3A4 inhibition (preclinical). Estrogenic activity.

YELLOW

AHCC (mushroom extract)

Induces CYP2D6. CYP2D6 is not a major apixaban pathway. Low concern for Eliquis.

GREEN

Graviola (soursop)

Additive hypoglycemia and hypotension (mouse). No direct anticoagulant interaction.

YELLOW

Coriolus versicolor (turkey tail)

Low interaction risk. May interact with immunosuppressants.

GREEN

Key MSK principle: Most herb-drug interaction data come from preclinical (in vitro and animal) studies. Clinical relevance in humans is often unknown. Culinary herbs in small quantities for flavoring are generally safe — concentrated supplement forms carry the interaction risk.

Practical Guidance

Before starting any supplement on apixaban:

  • Have your pharmacist check the actual supplement label against your full medication list. Combination products often contain hidden herbal blends.
  • Start one supplement at a time so any adverse effects can be attributed to the right product.
  • Watch for signs of increased bleeding: unusual bruising, nosebleeds, bleeding gums, blood in urine or stool, heavier menstrual periods.
  • Never stop or reduce apixaban to accommodate a supplement.

Seek urgent care for:

  • Black or tarry stools
  • Vomiting blood or material that looks like coffee grounds
  • Bleeding that will not stop with pressure
  • Severe new headache with weakness, dizziness, or vision changes
  • Unexpected heavy bruising without trauma

Label-reading tips:

  • Look for "proprietary blend" on the Supplement Facts panel — this often hides exact amounts of herbal ingredients.
  • Check for turmeric/curcumin, ginkgo, garlic extract, ginger extract, or vitamin E anywhere in ingredients.
  • "Natural" does not mean "no interaction." Many RED-list supplements are plant-derived.
  • If the label says "supports healthy circulation" or "promotes blood flow," assume antiplatelet activity and check before combining.

Sources

  • Drugs.com — Eliquis Drug Interactions (drugs.com/drug-interactions/apixaban,eliquis.html)
  • HelloPharmacist — Supplement-Drug Interaction Checker (hellopharmacist.com)
  • GoodRx — Eliquis Interactions (goodrx.com/eliquis/interactions)
  • MedFinder — Apixaban Drug Interactions (medfinder.com)
  • ISMP — Eliquis Patient Safety Guide
  • MSK About Herbs Database (mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine/herbs)
  • Lam et al. — Top 10 Dietary Supplements Among Cancer Patients, J Pharm Pract 2019 (PMC6777855)
  • MSK Reishi Mushroom Monograph (mskcc.org/cancer-care/integrative-medicine/herbs/reishi-mushroom)

As of November 2026. Interaction data evolves; verify current status with your pharmacist before making changes.

Read more